Hydroxychloroquine-induced erythema multiforme.

Dimitra KoumakiVasiliki KoumakiGeorge BertsiasSotirios BoumpoucheropoulosAlexander KatoulisMaria StefanidouOrestis MiarisGeorge EvangelouKyriaki ZografakiSabine Elke Krueger-KrasagakisKonstantinos Krasagakis

Published in: Clinical case reports (2020)

Hydroxychloroquine is a commonly used medication and rarely may result in development of erythema multiforme. This potential cutaneous side effect should be highlighted in information given to patients prior to hydroxychloroquine commencement.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
healthcare
prognostic factors
peritoneal dialysis
high glucose
diabetic rats
risk assessment
patient reported outcomes
drug induced
endothelial cells
human health
adverse drug
climate change
electronic health record